AM
JNJ icon

Atwater Malick’s Johnson & Johnson JNJ Stock Holding History

Atwater Malick’s Portfolio JNJ Stock Details JNJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.75M Sell
27,594
-4,017
-13% -$936K 1.82% 15
2025
Q4 		$6.54M Sell
31,611
-5,542
-15% -$1.1M 1.8% 15
2025
Q3 		$6.89M Sell
37,153
-11,843
-24% -$2.03M 2% 18
2025
Q2 		$7.48M Buy
48,996
+308
+0.6% +$47.3K 2.37% 18
2025
Q1 		$8.07M Buy
48,688
+973
+2% +$152K 2.73% 15
2024
Q4 		$6.9M Sell
47,715
-2,437
-5% -$378K 2.31% 19
2024
Q3 		$8.13M Buy
50,152
+312
+0.6% +$49.7K 2.62% 18
2024
Q2 		$7.28M Sell
49,840
-623
-1% -$92.7K 2.51% 18
2024
Q1 		$7.98M Buy
50,463
+610
+1% +$97.1K 2.81% 16
2023
Q4 		$7.81M Buy
49,853
+852
+2% +$131K 3.06% 15
2023
Q3 		$7.63M Buy
49,001
+1,770
+4% +$292K 3.36% 12
2023
Q2 		$7.82M Buy
47,231
+1,267
+3% +$204K 3.34% 13
2023
Q1 		$7.12M Buy
45,964
+1,233
+3% +$199K 3.34% 16
2022
Q4 		$7.9M Buy
44,731
+1,296
+3% +$224K 3.89% 10
2022
Q3 		$7.09M Buy
43,435
+1,104
+3% +$187K 3.96% 7
2022
Q2 		$7.51M Buy
42,331
+626
+2% +$112K 3.95% 9
2022
Q1 		$7.39M Buy
41,705
+1,487
+4% +$253K 3.57% 12
2021
Q4 		$6.88M Buy
40,218
+1,359
+3% +$222K 3.19% 16
2021
Q3 		$6.28M Buy
38,859
+1,337
+4% +$228K 3.32% 15
2021
Q2 		$6.18M Buy
37,522
+2,117
+6% +$350K 3.42% 14
2021
Q1 		$5.82M Sell
35,405
-2,047
-5% -$331K 3.57% 13
2020
Q4 		$5.89M Buy
37,452
+752
+2% +$111K 3.7% 12
2020
Q3 		$5.46M Buy
36,700
+875
+2% +$129K 3.83% 13
2020
Q2 		$5.04M Buy
35,825
+780
+2% +$114K 3.97% 9
2020
Q1 		$4.59M Buy
35,045
+1,815
+5% +$258K 4.41% 8
2019
Q4 		$4.85M Buy
33,230
+938
+3% +$127K 3.85% 12
2019
Q3 		$4.18M Buy
32,292
+831
+3% +$109K 3.51% 13
2019
Q2 		$4.38M Buy
31,461
+1,157
+4% +$160K 4.02% 13
2019
Q1 		$4.24M Buy
30,304
+649
+2% +$86.9K 4.14% 10
2018
Q4 		$3.83M Buy
+29,655
New +$4.14M 4.28% 11

Other funds holding JNJ

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Atwater Malick's JNJ Position: Q1 2026 in Review

Atwater Malick reduced its Johnson & Johnson (JNJ) stake by 13% in Q1 2026, selling an estimated $936K and leaving 27,594 shares worth $6.75M. The position accounts for 1.82% of the portfolio, ranked #15.

Atwater Malick first reported a position in JNJ in Q4 2018 and has held it in 30 quarters since. The position peaked at $8.13M in Q3 2024. 4,614 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Atwater Malick held 27,594 shares of Johnson & Johnson worth $6.75M as of Q1 2026.
  • Atwater Malick sold 4,017 Johnson & Johnson shares in Q1 2026, an estimated $936K.
  • Johnson & Johnson made up 1.82% of Atwater Malick's portfolio in Q1 2026, its #15 holding.
  • Atwater Malick first reported a position in Johnson & Johnson in Q4 2018 and has held it in 30 quarters since.
  • Atwater Malick's Johnson & Johnson position peaked at $8.13M in Q3 2024.
  • 4,614 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Atwater Malick's 13F filing for Q1 2026, filed 22 Apr 2026.